Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021

To assess the real-world impact of vaccines on COVID-19 related outcomes, we analysed data from over 7 million recipients of at least one COVID-19 vaccine dose in Italy. Taking 0–14 days post-first dose as reference, the SARS-CoV-2 infection risk subsequently decreased, reaching a reduction by 78% (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Euro Surveill
Main Authors: Mateo-Urdiales, Alberto, Spila Alegiani, Stefania, Fabiani, Massimo, Pezzotti, Patrizio, Filia, Antonietta, Massari, Marco, Riccardo, Flavia, Tallon, Marco, Proietti, Valeria, Del Manso, Martina, Puopolo, Maria, Spuri, Matteo, Morciano, Cristina, D’Ancona, Fortunato (Paolo), Da Cas, Roberto, Battilomo, Serena, Bella, Antonino, Menniti-Ippolito, Francesca
Formato: Artigo
Idioma:Inglês
Publicado em: European Centre for Disease Prevention and Control (ECDC) 2021
Assuntos:
Rapid Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8229378/
https://ncbi.nlm.nih.gov/pubmed/34169819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2021.26.25.2100507
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados